Access Bio, Inc.

950130· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩2,245-4.47%

2026-10-08

Financials

Valuation Metrics

Access Bio, Inc.'s Market Cap is ₩790B. At end of 2025 it was ₩1337B. Ranked #1460 of 2,419 in KR market (top 60%), #843 of 1,638 on KOSDAQ (top 51%), #161 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 70%) by Market Cap.

Investment Metrics(as of 2026-10-08)

Metric	Value	Rank
Size
Market Cap	78.97B KRW	KR#1,460/2,419 Sec#161/231
Revenue	23.82B KRW	KR—/2,419 Sec—/231
Net Income	-114.23B KRW	KR—/2,419 Sec—/231
Total Assets	631.40B KRW	KR—/2,419 Sec—/231
Net Assets	550.01B KRW	KR—/2,419 Sec—/231
Employees	130	KR#1,437/2,419 Sec#115/231
Value
P/B	0.14x	KR#47/2,419 Sec#3/231
P/S	3.32x	KR#2,014/2,419 Sec#126/231
Profitability
ROE	-20.77%	KR—/2,419 Sec—/231
ROA	-18.09%	KR—/2,419 Sec—/231
Op. Margin	-308.42%	KR—/2,419 Sec—/231
Revenue Growth	-71.24%	KR—/2,419 Sec—/231
Financial Health
Debt Ratio	14.80%	KR—/2,419 Sec—/231
Total Debt	88.11B KRW	KR—/2,419 Sec—/231
Cash	237.77B KRW	KR—/2,419 Sec—/231
Current Ratio	6.95x	KR—/2,419 Sec—/231
Performance
1Y Return	-51.72%	KR#2,126/2,419 Sec#196/231
1M Return	-8.74%	KR#2,044/2,419 Sec#193/231
From 52W High	-57.48%	KR#1,802/2,419 Sec#147/231
1Y MDD	-59.84%	KR#1,473/2,419 Sec#117/231
Trading
Volume	82,996 shares	KR#876/2,419 Sec#94/231
Trading Value	187.4M KRW	KR#1,335/2,419 Sec#151/231
Foreign Own.	4.75%	KR—/2,419 Sec—/231
Per Share
EPS	-3,248 KRW	KR—/2,419 Sec—/231
BPS	15,637 KRW	KR#676/2,419 Sec#44/231

Company Info

CEO Young-Ho Choi

Employees 130

HQ Monroe Township, US

Website https://accessbio.net

Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, immunochemical diagnosis, biosensor, and molecular diagnostic technology. Its products are diagnostic reagents that diagnose infectious diseases such as malaria, influenza, and Coronavirus. The company was founded on September 27, 2002 and is headquartered in Monroe Township, NJ.